Category: Health & Beauty

I am a dynamic author specialising in articles about technology, construction, and property. Originally from Italy, I blend my European perspective with a forward-thinking approach to deliver insightful and practical content.
  • Longevity Science Is No Longer for the Elite: The Mainstream Wellness Treatments Backed by New Research

    Longevity Science Is No Longer for the Elite: The Mainstream Wellness Treatments Backed by New Research

    For years, the science of living longer and healthier was the exclusive preserve of Californian tech billionaires with private physicians and seven-figure health budgets. Bryan Johnson making headlines by transfusing his son’s blood plasma. Peter Thiel reportedly banking on parabiosis. The whole enterprise had an air of the baroque, even the desperate. But something has shifted, and it has shifted quickly. The longevity treatments 2026 are increasingly grounded in rigorous clinical evidence, increasingly available through UK private clinics, and increasingly affordable for anyone who takes their health with reasonable seriousness. This is not wellness fluff. It is a genuine pharmaceutical and diagnostic revolution.

    A woman reviewing longevity treatments 2026 data with her physician in a London private clinic
    A woman reviewing longevity treatments 2026 data with her physician in a London private clinic

    What Are Senolytics and Why Should You Care?

    The most significant clinical development in ageing science over the past decade is the emergence of senolytics: compounds that selectively clear senescent cells from the body. Senescent cells are, in the bluntest terms, cells that have stopped dividing but refuse to die. They accumulate with age and secrete a cocktail of inflammatory proteins that damage surrounding tissue, driving conditions from arthritis to cardiovascular disease to cognitive decline.

    The leading senolytic combination studied in human trials is dasatinib and quercetin. Dasatinib is a leukaemia drug; quercetin is a plant flavonoid found in onions and capers. Together, they have shown promising results in trials at the Mayo Clinic and, more recently, at University College London, where researchers observed measurable reductions in senescent cell burden in older patients with idiopathic pulmonary fibrosis. The regime is typically administered in short, intermittent bursts rather than daily dosing, which reduces side-effect risk considerably.

    In the UK, quercetin supplements are freely available from brands such as Viridian and Solgar. Dasatinib, being a prescription drug regulated by the MHRA, requires clinical oversight. A growing number of London-based longevity clinics, including Harpal Clinic and the Hooke Longevity Clinic in Marylebone, now offer senolytic protocols under medical supervision, typically priced between £800 and £2,500 for an initial programme including bloodwork and follow-up. That is not trivial, but it is a far cry from the seven-figure territory of five years ago.

    Continuous Glucose Monitoring: The Most Democratised Longevity Tool of the Era

    Perhaps no single longevity technology has crossed from elite experimentation into mainstream use as decisively as continuous glucose monitoring, or CGM. Originally designed for diabetics, the small sensor worn on the upper arm now appears on the bodies of triathletes, hedge fund managers and, increasingly, people who simply want to understand how their diet affects their metabolic health in real time.

    The clinical rationale is compelling. Chronic glycaemic variability, even in people who test as non-diabetic on standard fasting glucose tests, is associated with accelerated biological ageing, cognitive impairment and elevated cardiovascular risk. A CGM device reveals exactly how your body responds to white rice versus brown, a croissant versus porridge, alcohol versus sleep deprivation. The feedback loop is immediate and, for most users, genuinely revelatory.

    In the UK, Abbott’s Libre Sense and the Dexterity platform have made CGM accessible without a prescription for non-diabetic users through services such as Zoe, the gut microbiome and metabolic health company co-founded by Professor Tim Spector of King’s College London. Zoe’s programme, which costs approximately £299 for the initial testing phase, combines CGM data with microbiome analysis and personalised dietary recommendations. The NHS uses CGM extensively for Type 1 diabetes management, and there is growing advocacy for wider metabolic screening, particularly following ONS data showing that an estimated 3.8 million people in England are living with pre-diabetes, many undiagnosed.

    Continuous glucose monitoring sensor worn on the arm, a key longevity treatment in 2026
    Continuous glucose monitoring sensor worn on the arm, a key longevity treatment in 2026

    NAD+ Precursors: The Supplement With the Most Clinical Weight

    Nicotinamide adenine dinucleotide, NAD+, is a coenzyme present in every cell in the body and central to energy metabolism and DNA repair. Its levels decline steeply with age. Supplementing with NAD+ precursors, principally nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), has become one of the most studied areas in longevity science, with human trials now published in peer-reviewed journals including Nature Ageing and Cell Metabolism.

    The results are not uniformly dramatic. Some studies show improved muscle function, cognitive clarity and reduced markers of inflammation in older adults. Others show more modest effects. What is clear is that NR and NMN are generally well tolerated and that their mechanism of action is biologically plausible in a way that many wellness supplements simply are not. Elysium Health’s Basis, containing NR and pterostilbene, has amassed more human trial data than almost any other longevity supplement on the market. In the UK, NMN supplements are available from Renue By Science and Double Wood Supplements, typically at £40 to £90 per month, putting them firmly within mainstream reach.

    Rapamycin: The Most Discussed Drug You Have Probably Never Heard Of

    Rapamycin is an immunosuppressant typically used to prevent organ transplant rejection. It is also the most consistently life-extending compound ever tested in animal models, including mice, where it extended median lifespan by up to 25 per cent even when administered late in life. It works by inhibiting mTOR, a signalling pathway that governs cell growth and metabolism, effectively nudging cells into a more cautious, repair-oriented mode.

    Human data is still limited but accumulating. The PEARL trial and ongoing work at the Karolinska Institute in Stockholm are among the more rigorous human studies. In the UK, off-label rapamycin prescribing for longevity purposes remains uncommon but not unheard of, and is available through select private longevity physicians at a cost of roughly £150 to £400 per month, including medical monitoring. The risks, including immunosuppression and potential impact on wound healing, mean this is emphatically not a supplement to acquire without professional oversight.

    For a thorough review of the current evidence on pharmacological longevity interventions, the Lancet has published several accessible analyses in recent years, and remains the most authoritative English-language source for clinically grounded readers.

    The Cost of Longevity in 2026: A Realistic Assessment

    The honest picture of longevity treatments 2026 is one of tiered accessibility. At the most accessible end, CGM programmes and NMN supplementation are available to anyone spending £50 to £100 per month. Mid-tier interventions, supervised senolytic protocols, comprehensive bloodwork panels measuring biological age via DNA methylation testing (available from companies such as Chronomics, based in the UK), and structured rapamycin regimes, sit in the £500 to £3,000 annual range. At the apex, full-service longevity clinics offering everything from hyperbaric oxygen therapy to DEXA body composition scanning charge upwards of £5,000 per year for membership packages.

    What has changed is not that the top tier has become cheaper, but that genuinely evidence-backed interventions now exist at every price point. The longevity treatments 2026 landscape no longer requires you to be Peter Thiel. It does require you to be informed, to engage with real clinical evidence rather than marketing, and to work with qualified medical professionals when prescription-grade interventions are involved. The science has never been more serious. That, at least, is worth something.

    Frequently Asked Questions

    What are the most evidence-backed longevity treatments available in the UK in 2026?

    The treatments with the strongest clinical evidence include continuous glucose monitoring for metabolic health, NAD+ precursor supplements such as NMN and NR, and senolytic protocols combining quercetin with dasatinib. Rapamycin is also gaining attention but requires careful medical supervision due to its immunosuppressant properties.

    How much do longevity treatments cost in the UK?

    Costs vary considerably. CGM programmes such as Zoe start at around £299 for an initial phase, NMN supplements cost roughly £40 to £90 per month, and supervised senolytic protocols at private UK clinics typically range from £800 to £2,500. Full-service longevity clinic memberships can exceed £5,000 per year.

    Are senolytics safe to take without medical supervision?

    Quercetin, a key component of the leading senolytic combination, is available over the counter and is generally considered safe. However, dasatinib is a prescription-only drug regulated by the MHRA and should only be taken under qualified medical supervision, as it carries meaningful side-effect risks.

    What is continuous glucose monitoring and do I need a prescription to use it?

    Continuous glucose monitoring involves wearing a small sensor, usually on the upper arm, that tracks blood sugar levels in real time throughout the day. In the UK, non-diabetic users can access CGM through services such as Zoe without a prescription, though NHS-funded CGM remains primarily reserved for patients with Type 1 diabetes.

    Does the NHS offer any longevity-focused treatments or interventions?

    The NHS does not currently offer longevity treatments as a distinct category. However, it does provide CGM for diabetes management, statins for cardiovascular risk reduction, and screening programmes for certain cancers and conditions associated with ageing. Most of the newer longevity interventions discussed in this article are available only through private clinics.

  • The Slow Travel Revolution: Why Discerning Travellers Are Abandoning Packed Itineraries for Depth Over Distance

    The Slow Travel Revolution: Why Discerning Travellers Are Abandoning Packed Itineraries for Depth Over Distance

    There is a particular kind of exhaustion that only seasoned travellers recognise. The one that arrives not after a long journey, but after a meticulously scheduled one. Three cities in five days. A museum before breakfast, a flight before dinner. The photographs are extraordinary; the memories, oddly thin. Slow travel luxury 2026 has emerged as a direct and rather elegant rebuke to all of that.

    This is not a fringe movement. Among Britain’s more thoughtful, culturally literate travellers, the shift is palpable and, by most accounts, permanent. The question is no longer how many places you can fit into a fortnight, but how deeply you can inhabit one. Depth over distance, as the phrase goes, has become the defining principle of a new kind of luxury.

    A traveller contemplating the Alentejo landscape, embodying the slow travel luxury 2026 philosophy
    A traveller contemplating the Alentejo landscape, embodying the slow travel luxury 2026 philosophy

    What Is the Slow Travel Philosophy, and Why Is It Resonating Now?

    Slow travel, at its core, borrows from the broader slow movement that emerged from Carlo Petrini’s Slow Food manifesto in late-1980s Italy. Applied to travel, it advocates staying longer in fewer places, engaging with local rhythms rather than tourist schedules, and measuring the success of a trip by what you understand at the end of it rather than what you have ticked off. Whilst the concept has circulated in travel writing for over a decade, something shifted meaningfully in 2025 and 2026 to push it from pleasant idea to genuine cultural force.

    Part of the answer is post-pandemic recalibration. British travellers who spent enforced periods at home rediscovered the pleasure of noticing things slowly, paying attention to what is immediately around them. Part of it is environmental consciousness; staying in one place for two weeks produces a fraction of the carbon footprint that a multi-destination tour generates. And part of it is, frankly, the luxury market doing what it always eventually does: following genuine desire rather than manufactured aspiration. High-net-worth travellers, the kind who once collected Michelin-starred restaurants across four countries in a single trip, are increasingly choosing a single villa in the Alentejo for ten nights, with a private guide and a reading list curated by a local academic.

    The Destinations Leading the Slow Travel Movement in 2026

    Not every place lends itself to the slow travel ideal. The best destinations share certain qualities: genuine local culture that rewards attention, landscapes that change with the light, food that is tied to place rather than trend, and enough quiet that you can hear yourself think.

    Portugal’s Alentejo region remains, by most measures, the spiritual home of slow travel luxury in 2026. Its cork forests, medieval hilltop towns and sparse, amber-lit plains feel designed for contemplation. Properties such as Herdade do Esporão have developed extended-stay programmes centred on viticulture, agricultural heritage and serious gastronomy. You arrive expecting a holiday and leave with something closer to an education.

    Japan’s Tohoku region, long overshadowed by Kyoto and Tokyo on the standard itinerary, has attracted substantial attention from discerning travellers seeking the country’s quieter self. Ryokan stays of a week or longer, centred on particular craft traditions such as Aizu lacquerware or Tsugaru shamisen music, have become genuinely sought-after experiences. The point is not observation but participation.

    Handcrafted ceramics and local produce reflecting the slow travel luxury 2026 attention to detail
    Handcrafted ceramics and local produce reflecting the slow travel luxury 2026 attention to detail

    Closer to home, Scotland’s far north has quietly become a destination of remarkable depth for slow travellers. The Orkney archipelago, in particular, offers something almost nowhere else can: a landscape that contains 5,000 years of human history, severe and luminous weather, and a local community of artists, farmers and archaeologists whose work is inseparable from the terrain. Several independent properties now offer week-long residencies built around the islands’ creative and academic communities. The scenery is, of course, spectacular. But scenery alone does not sustain a slow traveller; context does.

    Why Slow Travel and Luxury Are, in Fact, Natural Partners

    There is a common misconception that slow travel is austerity travel, that it means budget accommodation and a deliberate rejection of comfort. The opposite tends to be true at the upper end of the market. True slow travel luxury in 2026 is expensive precisely because it requires extraordinary quality at every point of sustained contact. One spectacular dinner is a treat; ten consecutive brilliant meals require a chef, a network of local producers and genuine culinary intelligence. One beautiful bedroom is easy to find; a space you can genuinely live in for a fortnight demands curation of an entirely different order.

    The most sophisticated slow travel operators understand this. Scott Dunn, the British luxury travel specialist, has reported significant growth in extended single-destination bookings over the past eighteen months, with clients increasingly requesting programmes that include private tutors, local mentors and curated cultural immersions rather than conventional excursions. The measure of success has shifted from novelty to understanding.

    This also represents a meaningful redefinition of exclusivity. In a world where most wealthy travellers have been everywhere, having been nowhere thoroughly is, perversely, the more distinguished position. To have spent three weeks in one Umbrian valley, to know the name of the farmer who produces your olive oil and the history of the church you walked past each morning, is a form of knowledge that no amount of itinerary-hopping can replicate.

    The Environmental Case, Which Is Impossible to Ignore

    Slow travel is not an environmental panacea, and it would be intellectually dishonest to pretend otherwise. Flying to Portugal and staying for three weeks still involves a flight to Portugal. But the arithmetic is notably better than flying to five destinations across a fortnight, and the emerging class of slow travellers is increasingly supplementing or replacing flights with long-distance rail journeys. The BBC’s science and environment coverage has consistently noted that aviation accounts for roughly 2.5 per cent of global CO2 emissions but a far higher share of effective climate warming when contrasted effects are included. Reducing flight frequency matters, even when total travel remains high.

    The overland renaissance is a significant subplot of the slow travel story. The Caledonian Sleeper from London to Inverness, the Venice Simplon-Orient Express, and a growing number of premium rail routes across Europe have attracted travellers who once would have flown without a second thought. The journey, in the slow travel model, is not an inconvenience to be minimised but a first act of the experience itself.

    How to Actually Do Slow Travel Well

    The practical barriers are real. Most Britons receive between 25 and 28 days of annual leave; a fortnight in one place feels extravagant to many. But slow travel need not mean extended sabbaticals. A long weekend in one Yorkshire village, properly engaged with, produces more lasting memory than four European capitals in a week. The philosophy scales.

    For those planning a genuine immersive trip, the principles are straightforward. Arrive without a checklist. Identify two or three things you genuinely want to understand, whether that is the local textile tradition, a regional cooking technique, or the history of a particular landscape, and build your time around those. Stay somewhere that feels like habitation rather than accommodation. Eat with the rhythm of local life. Walk more than you think necessary. Resist the hotel’s activity programme unless it genuinely interests you.

    The slow travel movement, at its best, is simply an argument for taking seriously the places we choose to visit. It asks travellers to bring their full attention rather than their best luggage. In a world that accelerates almost everything by default, that particular kind of deliberateness feels, unexpectedly, like the most radical luxury of all.

    Frequently Asked Questions

    What does slow travel actually mean in practice?

    Slow travel means staying in fewer destinations for longer periods, prioritising genuine engagement with local culture, food and landscape over ticking off attractions. Rather than visiting five countries in a fortnight, a slow traveller might spend ten days in a single region, building real knowledge of the place rather than a curated highlight reel.

    Is slow travel luxury more expensive than conventional luxury holidays?

    Extended stays of genuine quality tend to cost more in absolute terms, simply because high standards must be maintained over a longer period. However, per-day costs can be lower, and many travellers find the value proposition far superior, as the depth of experience is incomparably richer than a succession of brief, expensive stops.

    Which are the best slow travel destinations for British travellers in 2026?

    Portugal’s Alentejo, Japan’s Tohoku region and Scotland’s Orkney archipelago are among the most compelling options for culturally serious slow travellers this year. Each rewards extended attention with layers of history, food culture and landscape that a short visit cannot hope to reach.

    Is slow travel actually better for the environment?

    It is generally more environmentally efficient than multi-destination travel, as it reduces the total number of flights taken. Combining slow travel with overland rail options, such as the Caledonian Sleeper or European train routes, reduces the carbon impact further, though a transatlantic flight remains significant regardless of how long you stay.

    Can slow travel work with a standard British annual leave allowance?

    Absolutely. The principles of slow travel apply at any scale; a long weekend spent properly exploring one part of the English countryside is slow travel in spirit. For those planning longer trips, combining annual leave with bank holidays strategically can create ten to twelve day windows that work well for genuinely immersive experiences.

  • Microplastics Are Inside All of Us, Here Is What the Latest Science Says You Should Do About It

    Microplastics Are Inside All of Us, Here Is What the Latest Science Says You Should Do About It

    It is, by any measure, one of the more unsettling findings of the modern scientific era. Researchers have now confirmed the presence of microplastics in human blood, lungs, placentas, breast milk, and most recently, the walls of the heart. We are not talking about trace anomalies detectable only in laboratory conditions. A study published in the journal Environment International found plastic particles in the blood of 77 per cent of participants tested. The question is no longer whether microplastic contamination is happening inside us. The question is what, precisely, it is doing there.

    This is a field moving at extraordinary speed. What scientists knew with confidence two years ago now feels like the opening chapter of a far longer and more troubling story. The latest research is beginning to map not just the presence of these particles but their biological behaviour, and the implications are significant enough to warrant serious attention from anyone interested in their own health.

    Scientist examining evidence of microplastic contamination under a microscope in a UK research laboratory
    Scientist examining evidence of microplastic contamination under a microscope in a UK research laboratory

    What Are Microplastics and How Do They Enter the Body?

    Microplastics are fragments of plastic less than five millimetres in diameter, though many of the particles studied in human tissue are nanoscale, meaning they are invisible to the naked eye. They originate from the degradation of larger plastic items, from synthetic textiles, from plastic packaging, from tyres, from cosmetics, and from industrial processes. They enter the body primarily through ingestion and inhalation, though dermal absorption is also being investigated as a secondary route.

    The average person in the UK is estimated to consume roughly five grams of plastic per week, equivalent in mass to a credit card, according to research commissioned by WWF. Much of that arrives through drinking water, whether from the tap or bottled. Seafood is a significant vector. So is the simple act of heating food in plastic containers or drinking from plastic cups. The air inside most British homes contains measurable levels of airborne plastic fibres, shed from upholstered furniture, synthetic carpets, and clothing made from polyester or nylon.

    What the Latest Research on Health Implications Shows

    The 2024 and 2025 literature on microplastic contamination has produced findings that are difficult to dismiss. A landmark study published in the New England Journal of Medicine examined patients undergoing surgery for carotid artery disease and found those with microplastics present in their arterial plaque had a significantly higher risk of heart attack, stroke, and death within three years compared to those without. This is the first study to link microplastic presence in human tissue directly to hard clinical outcomes rather than simply noting accumulation.

    Separately, research from the University of Hull has examined the inflammatory response triggered by certain plastic particles in lung tissue. Polyethylene and polystyrene fragments appear to provoke a persistent low-grade inflammatory reaction that mirrors, in some respects, the kind of chronic inflammation associated with elevated risk of respiratory disease and certain cancers. Endocrine disruption is another axis of concern: several chemical additives leached by plastics, including phthalates and bisphenol A, are well-established hormone disruptors, and the evidence that plastic particles themselves may carry these compounds into deep tissue is mounting.

    What scientists are careful to emphasise is that causal mechanisms in humans are still being established. The correlations are striking. The biological plausibility is strong. But the field is honest about the fact that long-term population studies are still in relatively early stages. That said, the direction of travel in the evidence is, by most accounts, concerning rather than reassuring.

    Glass of filtered water on a British kitchen counter, an everyday step to reduce microplastic contamination
    Glass of filtered water on a British kitchen counter, an everyday step to reduce microplastic contamination

    How to Reduce Microplastic Exposure: Evidence-Based Steps

    Eliminating microplastic contamination entirely from modern life is not realistic. But the evidence does support meaningful reductions through targeted behavioural changes, and given what we now know about accumulation dynamics, reducing exposure from multiple vectors simultaneously is likely to have a compounding benefit.

    Switch to filtered tap water and avoid plastic bottles

    Bottled water, paradoxically, contains significantly higher concentrations of microplastics than properly filtered tap water. A study by researchers at Columbia University found an average of 240,000 plastic particles per litre in tested bottled water, most of them nanoplastics shed from the bottles themselves. Installing a quality under-sink filter with a pore size small enough to capture nano-scale particles, or using a certified filter jug, reduces exposure substantially. If you drink a lot of hot beverages, avoid paper cups: the inner lining is plastic, and heat accelerates particle release.

    Rethink how you heat and store food

    Never heat food in plastic containers, even those labelled microwave-safe. That designation relates to structural integrity, not to whether the plastic leaches particles into food when heated. Transfer leftovers to glass, ceramic, or stainless steel before reheating. Cling film should not be in contact with food during microwaving. Swap plastic chopping boards for wood or glass: a used woodworking machinery enthusiast building their own hardwood boards at home is, rather satisfyingly, making a genuinely health-conscious choice.

    Improve indoor air quality

    Airborne microplastics in the home come largely from synthetic textiles and carpets. Vacuuming regularly with a HEPA-filter vacuum, opening windows to improve ventilation, and choosing natural fibre furnishings where possible will reduce airborne particle counts. Washing synthetic clothing in a microplastic-catching laundry bag, such as those made by Guppyfriend, prevents fibres entering waterways and reduces the dispersal of particles into the home environment during washing.

    Reduce dietary exposure through food choices

    Seafood, particularly shellfish consumed whole, carries the highest dietary microplastic burden. That does not mean abandoning it entirely, but awareness is useful. Salt, honey, and beer have all been found to contain particles. Choosing foods packaged in glass, cardboard, or not packaged at all, particularly for acidic foods that accelerate plastic leaching, is a pragmatic and relatively low-effort adjustment.

    What the UK Government and Public Health Bodies Are Saying

    The UK Health Security Agency has acknowledged the growing body of evidence on microplastic contamination, though official guidance remains cautious pending more conclusive long-term studies. The Food Standards Agency published a research review noting that whilst current dietary exposure levels are unlikely to cause acute harm, chronic accumulation effects are not yet fully understood and warrant ongoing monitoring. That is the measured language of public health bodies navigating genuine scientific uncertainty. It should not be read as reassurance that the situation is without concern.

    The broader regulatory picture in the UK involves a gradual tightening of restrictions on single-use plastics and plastic packaging, with further measures expected under the extended producer responsibility framework. These are structural changes that will take years to alter the volume of plastic in circulation. Individual action, in the meantime, remains the most direct lever available.

    The Bigger Picture: A Crisis That Demands Structural Change

    Personal mitigation is valuable. But it is worth being clear-eyed about the scale of what we are dealing with. Microplastics have been found in the deepest ocean trenches, in Arctic ice cores, and in rainwater collected above remote mountain ranges. They are a systemic consequence of six decades of plastic production without adequate consideration of end-of-life dispersal. The UK produces roughly 1.7 million tonnes of plastic waste annually, according to the British Plastics Federation. Even the most conscientious individual choices operate against that backdrop.

    The science of microplastic contamination is moving faster than policy. What it is telling us, with increasing confidence, is that the particles accumulating in human tissue are not biologically inert. Addressing that will require action at every level, from the choices made in individual kitchens to the regulatory frameworks governing how plastic is manufactured, used, and disposed of. The evidence is now too substantial to defer either the concern or the response.

    Frequently Asked Questions

    Are microplastics really found inside the human body?

    Yes. Scientific studies have confirmed microplastics in human blood, lungs, liver, kidneys, placentas, breast milk, and arterial plaque. A 2022 study found plastic particles in the blood of 77 per cent of participants tested, and more recent research has linked accumulation in arterial tissue to increased cardiovascular risk.

    What are the most concerning health effects of microplastic contamination?

    The most significant recent finding links microplastics in arterial plaque to higher rates of heart attack and stroke. Researchers are also investigating chronic inflammation, endocrine disruption caused by chemical additives in plastics, and potential impacts on immune function, though causal mechanisms in humans are still being established.

    How can I reduce my microplastic exposure at home?

    Key steps include filtering tap water rather than drinking from plastic bottles, avoiding heating food in plastic containers, vacuuming regularly with a HEPA-filter vacuum, and choosing natural fibre textiles where possible. Switching to glass, ceramic, or stainless steel food storage makes a measurable difference.

    Is bottled water worse than tap water for microplastics?

    Yes, research consistently finds higher microplastic concentrations in bottled water than in filtered tap water, largely because plastic particles shed from the bottles themselves. Using a quality tap filter or certified filter jug is a more effective and environmentally sound alternative.

    What foods contain the most microplastics?

    Shellfish consumed whole carry the highest dietary burden, as the digestive systems where plastics accumulate are eaten along with the flesh. Sea salt, honey, and beer have also tested positive for particles. Foods stored or heated in plastic packaging tend to have higher contamination levels than those in glass or unpackaged alternatives.

The Latest